

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | sarcomere organization (GO:0045214) | 6.98109734 |
| 2 | plasma membrane repair (GO:0001778) | 6.05696437 |
| 3 | negative regulation of inclusion body assembly (GO:0090084) | 5.99690055 |
| 4 | cardiac myofibril assembly (GO:0055003) | 5.92082922 |
| 5 | actin-myosin filament sliding (GO:0033275) | 5.58310663 |
| 6 | muscle filament sliding (GO:0030049) | 5.58310663 |
| 7 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 5.54640148 |
| 8 | myofibril assembly (GO:0030239) | 5.49970597 |
| 9 | protein refolding (GO:0042026) | 5.29432031 |
| 10 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 5.12015977 |
| 11 | regulation of skeletal muscle contraction (GO:0014819) | 5.03532537 |
| 12 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 5.00958308 |
| 13 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 4.94759502 |
| 14 | hemidesmosome assembly (GO:0031581) | 4.86929321 |
| 15 | actin-mediated cell contraction (GO:0070252) | 4.77724825 |
| 16 | cardiac muscle cell development (GO:0055013) | 4.64412515 |
| 17 | actomyosin structure organization (GO:0031032) | 4.40071129 |
| 18 | cardiac cell development (GO:0055006) | 4.39509690 |
| 19 | cardiac muscle contraction (GO:0060048) | 4.38911795 |
| 20 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 4.36736173 |
| 21 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 4.35925157 |
| 22 | heart trabecula formation (GO:0060347) | 4.33652797 |
| 23 | carnitine shuttle (GO:0006853) | 4.30129689 |
| 24 | cardiac muscle tissue morphogenesis (GO:0055008) | 4.27052077 |
| 25 | tricarboxylic acid cycle (GO:0006099) | 4.24832436 |
| 26 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 4.22579664 |
| 27 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 4.18785578 |
| 28 | regulation of actin filament-based movement (GO:1903115) | 4.12137046 |
| 29 | ventricular cardiac muscle cell action potential (GO:0086005) | 4.10073172 |
| 30 | regulation of relaxation of muscle (GO:1901077) | 4.00285752 |
| 31 | cell-substrate junction assembly (GO:0007044) | 3.97615619 |
| 32 | muscle tissue morphogenesis (GO:0060415) | 3.93465014 |
| 33 | fatty acid transmembrane transport (GO:1902001) | 3.93239035 |
| 34 | skin morphogenesis (GO:0043589) | 3.91960776 |
| 35 | regulation of inclusion body assembly (GO:0090083) | 3.81256000 |
| 36 | cell-substrate adherens junction assembly (GO:0007045) | 3.73434245 |
| 37 | focal adhesion assembly (GO:0048041) | 3.73434245 |
| 38 | adult heart development (GO:0007512) | 3.71870863 |
| 39 | response to muscle activity (GO:0014850) | 3.70413968 |
| 40 | actin filament-based movement (GO:0030048) | 3.66881321 |
| 41 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 3.66834754 |
| 42 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.65146320 |
| 43 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.64742026 |
| 44 | adherens junction assembly (GO:0034333) | 3.62764666 |
| 45 | regulation of sequestering of triglyceride (GO:0010889) | 3.61931938 |
| 46 | striated muscle contraction (GO:0006941) | 3.54866261 |
| 47 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.50696999 |
| 48 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 3.49826295 |
| 49 | Golgi transport vesicle coating (GO:0048200) | 3.44830063 |
| 50 | COPI coating of Golgi vesicle (GO:0048205) | 3.44830063 |
| 51 | regulation of striated muscle contraction (GO:0006942) | 3.37065553 |
| 52 | heart contraction (GO:0060047) | 3.34091064 |
| 53 | heart process (GO:0003015) | 3.34091064 |
| 54 | cellular response to arsenic-containing substance (GO:0071243) | 3.31469381 |
| 55 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 3.29733714 |
| 56 | cardiac muscle hypertrophy (GO:0003300) | 3.27051458 |
| 57 | negative regulation of cardiac muscle cell apoptotic process (GO:0010667) | 3.26714098 |
| 58 | striated muscle hypertrophy (GO:0014897) | 3.26033705 |
| 59 | muscle cell cellular homeostasis (GO:0046716) | 3.24286951 |
| 60 | regulation of fatty acid oxidation (GO:0046320) | 3.23765142 |
| 61 | regulation of cell communication by electrical coupling (GO:0010649) | 3.23270554 |
| 62 | carnitine transmembrane transport (GO:1902603) | 3.21583480 |
| 63 | trabecula formation (GO:0060343) | 3.20850636 |
| 64 | regulation of cardioblast differentiation (GO:0051890) | 3.20373901 |
| 65 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 3.19818665 |
| 66 | regulation of p38MAPK cascade (GO:1900744) | 3.19283649 |
| 67 | 2-oxoglutarate metabolic process (GO:0006103) | 3.19244295 |
| 68 | regulation of the force of heart contraction (GO:0002026) | 3.17212914 |
| 69 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 3.14619684 |
| 70 | creatine metabolic process (GO:0006600) | 3.09571422 |
| 71 | epithelial cell-cell adhesion (GO:0090136) | 3.09107968 |
| 72 | desmosome organization (GO:0002934) | 3.04935628 |
| 73 | cell communication involved in cardiac conduction (GO:0086065) | 3.01965356 |
| 74 | atrioventricular valve morphogenesis (GO:0003181) | 3.01683541 |
| 75 | regulation of tight junction assembly (GO:2000810) | 2.97826670 |
| 76 | positive regulation of fatty acid oxidation (GO:0046321) | 2.97390707 |
| 77 | muscle hypertrophy (GO:0014896) | 2.96872637 |
| 78 | regulation of early endosome to late endosome transport (GO:2000641) | 2.95500968 |
| 79 | amino-acid betaine transport (GO:0015838) | 2.94286114 |
| 80 | carnitine transport (GO:0015879) | 2.94286114 |
| 81 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.93518141 |
| 82 | fatty acid beta-oxidation (GO:0006635) | 2.89853599 |
| 83 | glycogen biosynthetic process (GO:0005978) | 2.86112375 |
| 84 | glucan biosynthetic process (GO:0009250) | 2.86112375 |
| 85 | positive regulation of p38MAPK cascade (GO:1900745) | 2.84201139 |
| 86 | regulation of sarcomere organization (GO:0060297) | 2.83846297 |
| 87 | skeletal muscle adaptation (GO:0043501) | 2.83293706 |
| 88 | muscle contraction (GO:0006936) | 2.79541748 |
| 89 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 2.78671534 |
| 90 | NADH metabolic process (GO:0006734) | 2.78611655 |
| 91 | response to unfolded protein (GO:0006986) | 2.78461036 |
| 92 | endothelial cell chemotaxis (GO:0035767) | 2.78236013 |
| 93 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.77858379 |
| 94 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.77568469 |
| 95 | regulation of cardiac muscle cell contraction (GO:0086004) | 2.77528263 |
| 96 | striated muscle cell development (GO:0055002) | 2.76174819 |
| 97 | lysine metabolic process (GO:0006553) | 2.75857499 |
| 98 | lysine catabolic process (GO:0006554) | 2.75857499 |
| 99 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.74464313 |
| 100 | protein hydroxylation (GO:0018126) | 2.73792054 |
| 101 | regulation of cardiac muscle contraction (GO:0055117) | 2.72913319 |
| 102 | regulation of membrane repolarization (GO:0060306) | 2.72099550 |
| 103 | regulation of water loss via skin (GO:0033561) | 2.71263374 |
| 104 | regulation of ATP catabolic process (GO:1903289) | 2.70219507 |
| 105 | regulation of ATPase activity (GO:0043462) | 2.70219507 |
| 106 | regulation of heart rate (GO:0002027) | 2.69231866 |
| 107 | positive regulation of heart contraction (GO:0045823) | 2.68415926 |
| 108 | negative regulation of heart growth (GO:0061117) | 2.67810511 |
| 109 | negative regulation of cardiac muscle tissue growth (GO:0055022) | 2.67810511 |
| 110 | negative regulation of chondrocyte differentiation (GO:0032331) | 2.67551515 |
| 111 | 4-hydroxyproline metabolic process (GO:0019471) | 2.67165552 |
| 112 | positive regulation of astrocyte differentiation (GO:0048711) | 2.66762628 |
| 113 | skeletal muscle contraction (GO:0003009) | 2.66611621 |
| 114 | mammary gland epithelial cell proliferation (GO:0033598) | 2.65225862 |
| 115 | cell adhesion mediated by integrin (GO:0033627) | 2.65035472 |
| 116 | skeletal muscle fiber development (GO:0048741) | 2.64130198 |
| 117 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.61587434 |
| 118 | muscle system process (GO:0003012) | 2.61236108 |
| 119 | ventricular cardiac muscle cell development (GO:0055015) | 2.60859040 |
| 120 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.60590633 |
| 121 | response to topologically incorrect protein (GO:0035966) | 2.59883322 |
| 122 | peptidyl-proline hydroxylation (GO:0019511) | 2.59340189 |
| 123 | oxygen transport (GO:0015671) | 2.58382649 |
| 124 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.57845745 |
| 125 | negative regulation of potassium ion transport (GO:0043267) | 2.57597831 |
| 126 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 2.57593811 |
| 127 | basement membrane organization (GO:0071711) | 2.57386625 |
| 128 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.57316215 |
| 129 | ER overload response (GO:0006983) | 2.54640002 |
| 130 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.54535529 |
| 131 | positive regulation of lipid storage (GO:0010884) | 2.54410494 |
| 132 | regulation of coenzyme metabolic process (GO:0051196) | 2.54222195 |
| 133 | regulation of cofactor metabolic process (GO:0051193) | 2.54222195 |
| 134 | aspartate family amino acid catabolic process (GO:0009068) | 2.53581029 |
| 135 | protein localization to endosome (GO:0036010) | 2.52474491 |
| 136 | kidney mesenchyme development (GO:0072074) | 2.51535361 |
| 137 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.48172446 |
| 138 | wound healing, spreading of epidermal cells (GO:0035313) | 2.47994449 |
| 139 | heart valve morphogenesis (GO:0003179) | 2.47351396 |
| 140 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.44893151 |
| 141 | keratinocyte proliferation (GO:0043616) | 2.44401528 |
| 142 | gluconeogenesis (GO:0006094) | 2.43345620 |
| 143 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 2.41228675 |
| 144 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 2.40126797 |
| 145 | muscle cell migration (GO:0014812) | 2.39875879 |
| 146 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.36695041 |
| 147 | negative regulation of myoblast differentiation (GO:0045662) | 2.34646760 |
| 148 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.34329679 |
| 149 | glomerular basement membrane development (GO:0032836) | 2.31078548 |
| 150 | regulation of transforming growth factor beta2 production (GO:0032909) | 2.30607696 |
| 151 | hexose biosynthetic process (GO:0019319) | 2.29782424 |
| 152 | protein heterotrimerization (GO:0070208) | 2.29438045 |
| 153 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 2.29282726 |
| 154 | myoblast fusion (GO:0007520) | 2.29049924 |
| 155 | positive regulation of extracellular matrix organization (GO:1903055) | 2.27748786 |
| 156 | protein retention in ER lumen (GO:0006621) | 2.27308133 |
| 157 | regulation of myoblast differentiation (GO:0045661) | 2.27287117 |
| 158 | endodermal cell differentiation (GO:0035987) | 2.26980430 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.40865434 |
| 2 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 4.25701910 |
| 3 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.83205496 |
| 4 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 3.61526930 |
| 5 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.44094678 |
| 6 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.40515135 |
| 7 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.90917260 |
| 8 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 2.75474796 |
| 9 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.59096917 |
| 10 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 2.55142415 |
| 11 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 2.55142415 |
| 12 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.53287402 |
| 13 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.53014597 |
| 14 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 2.51297275 |
| 15 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.46310383 |
| 16 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.43638122 |
| 17 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.31046145 |
| 18 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.28200402 |
| 19 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.27528606 |
| 20 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.06817830 |
| 21 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 2.00204771 |
| 22 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.99850522 |
| 23 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.99423883 |
| 24 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.96062169 |
| 25 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.92600637 |
| 26 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.90742468 |
| 27 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.90606890 |
| 28 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.89554089 |
| 29 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.89294250 |
| 30 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.74329634 |
| 31 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.73590187 |
| 32 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.65677458 |
| 33 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.64073747 |
| 34 | ATF3_27146783_Chip-Seq_COLON_Human | 1.62722208 |
| 35 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.60012573 |
| 36 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.58977071 |
| 37 | * ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.57535480 |
| 38 | * CJUN_26792858_Chip-Seq_BT549_Human | 1.57279654 |
| 39 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.53596301 |
| 40 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.52008007 |
| 41 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.50158227 |
| 42 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.49139604 |
| 43 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.48888307 |
| 44 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.48775632 |
| 45 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.47884953 |
| 46 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.43013162 |
| 47 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.42944382 |
| 48 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.42034408 |
| 49 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.38938816 |
| 50 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.38465811 |
| 51 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.38451634 |
| 52 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.38034144 |
| 53 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.36314602 |
| 54 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.35269177 |
| 55 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.34976993 |
| 56 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.34710437 |
| 57 | * NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.33748606 |
| 58 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.33200403 |
| 59 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.28697513 |
| 60 | * GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.26291695 |
| 61 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.24657837 |
| 62 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.23555457 |
| 63 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.21957511 |
| 64 | * JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.21468915 |
| 65 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.19014304 |
| 66 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.18998535 |
| 67 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.18998535 |
| 68 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.18868065 |
| 69 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.17850258 |
| 70 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.17717666 |
| 71 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.17695836 |
| 72 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.17173610 |
| 73 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.16843547 |
| 74 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.14064268 |
| 75 | * CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.13852959 |
| 76 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.12551517 |
| 77 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.11372316 |
| 78 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.09671882 |
| 79 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.08218946 |
| 80 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.07661006 |
| 81 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.06992348 |
| 82 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.06023255 |
| 83 | * UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.05406491 |
| 84 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 1.04795484 |
| 85 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.04403895 |
| 86 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.04214516 |
| 87 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.03657558 |
| 88 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.02709281 |
| 89 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.02709281 |
| 90 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.01192035 |
| 91 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.00401590 |
| 92 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.00386977 |
| 93 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.98565089 |
| 94 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.98331829 |
| 95 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.98003617 |
| 96 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.96386373 |
| 97 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.96120221 |
| 98 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.95800607 |
| 99 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.95092735 |
| 100 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.94205188 |
| 101 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.93943419 |
| 102 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.93510090 |
| 103 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.92696691 |
| 104 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.92576094 |
| 105 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.92139934 |
| 106 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.91634839 |
| 107 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.90053563 |
| 108 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.89134189 |
| 109 | * HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.89067425 |
| 110 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.88092217 |
| 111 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.87814687 |
| 112 | KDM2B_26808549_Chip-Seq_K562_Human | 0.87678594 |
| 113 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.87501989 |
| 114 | * TP63_22573176_ChIP-Seq_HFKS_Human | 0.87481036 |
| 115 | * TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.86438650 |
| 116 | GATA1_19941826_ChIP-Seq_K562_Human | 0.85799635 |
| 117 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.85473501 |
| 118 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.84885365 |
| 119 | BRD4_25478319_ChIP-Seq_HGPS_Human | 0.84781346 |
| 120 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.84570071 |
| 121 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.84144445 |
| 122 | * GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.84042241 |
| 123 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.83108058 |
| 124 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.82188070 |
| 125 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.81946466 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002837_dystrophic_cardiac_calcinosis | 4.99736467 |
| 2 | MP0004084_abnormal_cardiac_muscle | 4.35641689 |
| 3 | MP0003646_muscle_fatigue | 4.30947390 |
| 4 | MP0000751_myopathy | 4.06458703 |
| 5 | MP0008438_abnormal_cutaneous_collagen | 3.24148448 |
| 6 | MP0004036_abnormal_muscle_relaxation | 3.18423543 |
| 7 | MP0005330_cardiomyopathy | 3.06818621 |
| 8 | * MP0000749_muscle_degeneration | 3.00402599 |
| 9 | MP0004215_abnormal_myocardial_fiber | 2.97332479 |
| 10 | MP0000750_abnormal_muscle_regeneration | 2.88241207 |
| 11 | MP0005451_abnormal_body_composition | 2.67352511 |
| 12 | * MP0004087_abnormal_muscle_fiber | 2.58562487 |
| 13 | MP0003705_abnormal_hypodermis_morpholog | 2.49933382 |
| 14 | MP0002972_abnormal_cardiac_muscle | 2.44725500 |
| 15 | MP0005275_abnormal_skin_tensile | 2.39465553 |
| 16 | MP0008775_abnormal_heart_ventricle | 2.36746643 |
| 17 | MP0003279_aneurysm | 2.35891613 |
| 18 | MP0009780_abnormal_chondrocyte_physiolo | 2.30275636 |
| 19 | MP0002796_impaired_skin_barrier | 2.17274993 |
| 20 | MP0005385_cardiovascular_system_phenoty | 2.16533216 |
| 21 | MP0001544_abnormal_cardiovascular_syste | 2.16533216 |
| 22 | MP0010234_abnormal_vibrissa_follicle | 2.14951677 |
| 23 | * MP0010630_abnormal_cardiac_muscle | 2.10567336 |
| 24 | MP0005503_abnormal_tendon_morphology | 2.10046107 |
| 25 | MP0006138_congestive_heart_failure | 2.09627814 |
| 26 | MP0005620_abnormal_muscle_contractility | 2.09389720 |
| 27 | MP0002106_abnormal_muscle_physiology | 2.07332728 |
| 28 | MP0000579_abnormal_nail_morphology | 2.01439654 |
| 29 | MP0004130_abnormal_muscle_cell | 1.98643307 |
| 30 | MP0002269_muscular_atrophy | 1.97845783 |
| 31 | MP0004484_altered_response_of | 1.94605539 |
| 32 | MP0003566_abnormal_cell_adhesion | 1.87129344 |
| 33 | MP0010368_abnormal_lymphatic_system | 1.86286061 |
| 34 | * MP0000759_abnormal_skeletal_muscle | 1.83112898 |
| 35 | MP0005369_muscle_phenotype | 1.81835389 |
| 36 | MP0000747_muscle_weakness | 1.78206133 |
| 37 | MP0004145_abnormal_muscle_electrophysio | 1.75725026 |
| 38 | MP0003137_abnormal_impulse_conducting | 1.73319175 |
| 39 | MP0000467_abnormal_esophagus_morphology | 1.73126243 |
| 40 | MP0000343_altered_response_to | 1.71501174 |
| 41 | MP0005670_abnormal_white_adipose | 1.60091504 |
| 42 | MP0004272_abnormal_basement_membrane | 1.59244183 |
| 43 | * MP0003828_pulmonary_edema | 1.56595193 |
| 44 | MP0003453_abnormal_keratinocyte_physiol | 1.54305613 |
| 45 | MP0005666_abnormal_adipose_tissue | 1.52295501 |
| 46 | MP0003950_abnormal_plasma_membrane | 1.46159085 |
| 47 | MP0004233_abnormal_muscle_weight | 1.41719264 |
| 48 | MP0009840_abnormal_foam_cell | 1.39079100 |
| 49 | MP0005623_abnormal_meninges_morphology | 1.38661557 |
| 50 | MP0002108_abnormal_muscle_morphology | 1.38376048 |
| 51 | MP0005501_abnormal_skin_physiology | 1.30913126 |
| 52 | MP0001849_ear_inflammation | 1.30758545 |
| 53 | MP0002127_abnormal_cardiovascular_syste | 1.30113300 |
| 54 | MP0004185_abnormal_adipocyte_glucose | 1.29966709 |
| 55 | MP0004085_abnormal_heartbeat | 1.29183972 |
| 56 | MP0001958_emphysema | 1.27315217 |
| 57 | MP0004510_myositis | 1.24282034 |
| 58 | MP0002332_abnormal_exercise_endurance | 1.22526806 |
| 59 | MP0005165_increased_susceptibility_to | 1.20499001 |
| 60 | MP0000733_abnormal_muscle_development | 1.18093003 |
| 61 | MP0000767_abnormal_smooth_muscle | 1.16076434 |
| 62 | MP0005375_adipose_tissue_phenotype | 1.15042302 |
| 63 | MP0009053_abnormal_anal_canal | 1.13711851 |
| 64 | MP0005409_darkened_coat_color | 1.12811705 |
| 65 | MP0005023_abnormal_wound_healing | 1.08832741 |
| 66 | MP0000537_abnormal_urethra_morphology | 1.07901526 |
| 67 | MP0003806_abnormal_nucleotide_metabolis | 1.06847941 |
| 68 | MP0001879_abnormal_lymphatic_vessel | 1.06455975 |
| 69 | * MP0003221_abnormal_cardiomyocyte_apopto | 1.05261000 |
| 70 | MP0006036_abnormal_mitochondrial_physio | 1.04661603 |
| 71 | * MP0000266_abnormal_heart_morphology | 1.01918180 |
| 72 | MP0002128_abnormal_blood_circulation | 1.00886029 |
| 73 | MP0001216_abnormal_epidermal_layer | 1.00873158 |
| 74 | MP0003567_abnormal_fetal_cardiomyocyte | 1.00336939 |
| 75 | MP0005083_abnormal_biliary_tract | 0.99586359 |
| 76 | MP0009250_abnormal_appendicular_skeleto | 0.98376246 |
| 77 | MP0001299_abnormal_eye_distance/ | 0.96366853 |
| 78 | MP0005076_abnormal_cell_differentiation | 0.95975454 |
| 79 | MP0002295_abnormal_pulmonary_circulatio | 0.95783858 |
| 80 | MP0000678_abnormal_parathyroid_gland | 0.92216289 |
| 81 | MP0006054_spinal_hemorrhage | 0.91898451 |
| 82 | MP0000534_abnormal_ureter_morphology | 0.91113577 |
| 83 | MP0009384_cardiac_valve_regurgitation | 0.85854939 |
| 84 | MP0002098_abnormal_vibrissa_morphology | 0.84089648 |
| 85 | MP0002060_abnormal_skin_morphology | 0.83808855 |
| 86 | MP0005508_abnormal_skeleton_morphology | 0.83803576 |
| 87 | MP0002234_abnormal_pharynx_morphology | 0.81443395 |
| 88 | MP0005319_abnormal_enzyme/_coenzyme | 0.81403087 |
| 89 | MP0002877_abnormal_melanocyte_morpholog | 0.79696251 |
| 90 | MP0008260_abnormal_autophagy | 0.79549071 |
| 91 | MP0000013_abnormal_adipose_tissue | 0.78295352 |
| 92 | MP0004264_abnormal_extraembryonic_tissu | 0.78286678 |
| 93 | MP0002249_abnormal_larynx_morphology | 0.78142490 |
| 94 | MP0003315_abnormal_perineum_morphology | 0.77931950 |
| 95 | MP0000003_abnormal_adipose_tissue | 0.76793015 |
| 96 | MP0003091_abnormal_cell_migration | 0.76132949 |
| 97 | MP0001243_abnormal_dermal_layer | 0.76099278 |
| 98 | MP0003191_abnormal_cellular_cholesterol | 0.74917012 |
| 99 | MP0003195_calcinosis | 0.73729557 |
| 100 | MP0010771_integument_phenotype | 0.71909642 |
| 101 | MP0002089_abnormal_postnatal_growth/wei | 0.71735580 |
| 102 | MP0010352_gastrointestinal_tract_polyps | 0.71037155 |
| 103 | MP0000230_abnormal_systemic_arterial | 0.69670811 |
| 104 | MP0005085_abnormal_gallbladder_physiolo | 0.68703475 |
| 105 | MP0010678_abnormal_skin_adnexa | 0.68531117 |
| 106 | MP0000249_abnormal_blood_vessel | 0.68352190 |
| 107 | MP0005257_abnormal_intraocular_pressure | 0.67923930 |
| 108 | MP0003045_fibrosis | 0.67357498 |
| 109 | MP0000627_abnormal_mammary_gland | 0.67142619 |
| 110 | MP0001614_abnormal_blood_vessel | 0.67022038 |
| 111 | MP0002925_abnormal_cardiovascular_devel | 0.64566179 |
| 112 | MP0002971_abnormal_brown_adipose | 0.64540854 |
| 113 | MP0001542_abnormal_bone_strength | 0.63797437 |
| 114 | MP0002896_abnormal_bone_mineralization | 0.63663534 |
| 115 | MP0004858_abnormal_nervous_system | 0.63366279 |
| 116 | MP0005266_abnormal_metabolism | 0.61019130 |
| 117 | MP0010030_abnormal_orbit_morphology | 0.59596388 |
| 118 | MP0003252_abnormal_bile_duct | 0.58929015 |
| 119 | MP0005595_abnormal_vascular_smooth | 0.54615924 |
| 120 | MP0009115_abnormal_fat_cell | 0.53918866 |
| 121 | MP0002933_joint_inflammation | 0.53208502 |
| 122 | MP0000762_abnormal_tongue_morphology | 0.52357686 |
| 123 | MP0003186_abnormal_redox_activity | 0.51673343 |
| 124 | MP0003656_abnormal_erythrocyte_physiolo | 0.50251279 |
| 125 | MP0005390_skeleton_phenotype | 0.49977217 |
| 126 | MP0005332_abnormal_amino_acid | 0.48445972 |
| 127 | MP0005058_abnormal_lysosome_morphology | 0.48268571 |
| 128 | * MP0002118_abnormal_lipid_homeostasis | 0.47034052 |
| 129 | MP0003941_abnormal_skin_development | 0.45750341 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Muscle fiber splitting (HP:0003555) | 5.93912453 |
| 2 | Sudden death (HP:0001699) | 5.84521945 |
| 3 | Ventricular tachycardia (HP:0004756) | 5.58265237 |
| 4 | Increased connective tissue (HP:0009025) | 5.15171801 |
| 5 | Hyporeflexia of lower limbs (HP:0002600) | 5.09483483 |
| 6 | Right ventricular cardiomyopathy (HP:0011663) | 4.91367215 |
| 7 | Exercise-induced muscle cramps (HP:0003710) | 4.89772036 |
| 8 | Calf muscle hypertrophy (HP:0008981) | 4.71397898 |
| 9 | Exercise-induced myalgia (HP:0003738) | 4.47113509 |
| 10 | Atrial fibrillation (HP:0005110) | 4.41085061 |
| 11 | Abnormality of the calf musculature (HP:0001430) | 4.37248378 |
| 12 | Muscle hypertrophy of the lower extremities (HP:0008968) | 4.29514458 |
| 13 | * Lipoatrophy (HP:0100578) | 4.14806840 |
| 14 | Primary atrial arrhythmia (HP:0001692) | 4.10036767 |
| 15 | Supraventricular tachycardia (HP:0004755) | 3.92168430 |
| 16 | Supraventricular arrhythmia (HP:0005115) | 3.89575006 |
| 17 | Myoglobinuria (HP:0002913) | 3.86534567 |
| 18 | Asymmetric septal hypertrophy (HP:0001670) | 3.85219726 |
| 19 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.72316743 |
| 20 | Subaortic stenosis (HP:0001682) | 3.72316743 |
| 21 | Difficulty climbing stairs (HP:0003551) | 3.64029691 |
| 22 | Distal lower limb muscle weakness (HP:0009053) | 3.59565376 |
| 23 | Difficulty running (HP:0009046) | 3.55587045 |
| 24 | Bundle branch block (HP:0011710) | 3.52587417 |
| 25 | Type 1 muscle fiber predominance (HP:0003803) | 3.50246817 |
| 26 | Palpitations (HP:0001962) | 3.48724904 |
| 27 | Premature rupture of membranes (HP:0001788) | 3.48166881 |
| 28 | Myopathic facies (HP:0002058) | 3.47414108 |
| 29 | Dilated cardiomyopathy (HP:0001644) | 3.47056923 |
| 30 | * EMG: myopathic abnormalities (HP:0003458) | 3.46886250 |
| 31 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 3.43602889 |
| 32 | Protrusio acetabuli (HP:0003179) | 3.42608042 |
| 33 | Syncope (HP:0001279) | 3.29449103 |
| 34 | Myotonia (HP:0002486) | 3.19355860 |
| 35 | Abnormal atrioventricular conduction (HP:0005150) | 3.12131919 |
| 36 | Rhabdomyolysis (HP:0003201) | 3.08771803 |
| 37 | Ventricular arrhythmia (HP:0004308) | 3.00713038 |
| 38 | Broad metatarsal (HP:0001783) | 2.98558991 |
| 39 | Heart block (HP:0012722) | 2.98539649 |
| 40 | Atrioventricular block (HP:0001678) | 2.97819805 |
| 41 | Prolonged QT interval (HP:0001657) | 2.96798130 |
| 42 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.84511901 |
| 43 | Muscle fiber inclusion bodies (HP:0100299) | 2.82411180 |
| 44 | Increased variability in muscle fiber diameter (HP:0003557) | 2.82008158 |
| 45 | Ulnar deviation of the wrist (HP:0003049) | 2.81929958 |
| 46 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.75244009 |
| 47 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.67107752 |
| 48 | Rimmed vacuoles (HP:0003805) | 2.60567415 |
| 49 | Areflexia of lower limbs (HP:0002522) | 2.55576538 |
| 50 | Bulbar palsy (HP:0001283) | 2.48148589 |
| 51 | Distal lower limb amyotrophy (HP:0008944) | 2.47774641 |
| 52 | Muscle stiffness (HP:0003552) | 2.47129550 |
| 53 | Hypoglycemic coma (HP:0001325) | 2.47074762 |
| 54 | Achilles tendon contracture (HP:0001771) | 2.44566652 |
| 55 | Slender build (HP:0001533) | 2.43009443 |
| 56 | Limb-girdle muscle atrophy (HP:0003797) | 2.42228385 |
| 57 | Hypoplastic ischia (HP:0003175) | 2.38526235 |
| 58 | Alopecia of scalp (HP:0002293) | 2.35576634 |
| 59 | Ventricular fibrillation (HP:0001663) | 2.31713125 |
| 60 | Ankle contracture (HP:0006466) | 2.28699628 |
| 61 | Neck muscle weakness (HP:0000467) | 2.27145920 |
| 62 | Nuclear cataract (HP:0100018) | 2.27020761 |
| 63 | Abnormality of the ischium (HP:0003174) | 2.24471895 |
| 64 | Ketoacidosis (HP:0001993) | 2.23899167 |
| 65 | Abnormality of the shoulder girdle musculature (HP:0001435) | 2.20711335 |
| 66 | Testicular atrophy (HP:0000029) | 2.18808602 |
| 67 | * Generalized amyotrophy (HP:0003700) | 2.15711909 |
| 68 | Cerebral aneurysm (HP:0004944) | 2.15076431 |
| 69 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.13481076 |
| 70 | Abnormality of the Achilles tendon (HP:0005109) | 2.12694539 |
| 71 | Shoulder girdle muscle weakness (HP:0003547) | 2.12292850 |
| 72 | Vascular tortuosity (HP:0004948) | 2.09841387 |
| 73 | Follicular hyperkeratosis (HP:0007502) | 2.08957232 |
| 74 | Foot dorsiflexor weakness (HP:0009027) | 2.07590862 |
| 75 | Broad face (HP:0000283) | 2.06504978 |
| 76 | Round ear (HP:0100830) | 2.05918931 |
| 77 | Nemaline bodies (HP:0003798) | 2.05769407 |
| 78 | * Spinal rigidity (HP:0003306) | 2.05105329 |
| 79 | Scapular winging (HP:0003691) | 2.03331306 |
| 80 | Facial diplegia (HP:0001349) | 2.02694986 |
| 81 | Abnormality of the foot musculature (HP:0001436) | 2.01569412 |
| 82 | Abnormal EKG (HP:0003115) | 1.99989624 |
| 83 | Short nail (HP:0001799) | 1.99383927 |
| 84 | Frequent falls (HP:0002359) | 1.99293340 |
| 85 | Arterial tortuosity (HP:0005116) | 1.99057012 |
| 86 | Mitral regurgitation (HP:0001653) | 1.97843473 |
| 87 | Fragile skin (HP:0001030) | 1.95309092 |
| 88 | Polycythemia (HP:0001901) | 1.95077562 |
| 89 | * Palmoplantar keratoderma (HP:0000982) | 1.94466203 |
| 90 | Aortic aneurysm (HP:0004942) | 1.94290622 |
| 91 | Distal arthrogryposis (HP:0005684) | 1.92844494 |
| 92 | Pterygium (HP:0001059) | 1.92502288 |
| 93 | Distal upper limb amyotrophy (HP:0007149) | 1.92257060 |
| 94 | Upper limb amyotrophy (HP:0009129) | 1.92257060 |
| 95 | Milia (HP:0001056) | 1.91526813 |
| 96 | Fragile nails (HP:0001808) | 1.91407588 |
| 97 | Elbow flexion contracture (HP:0002987) | 1.90500729 |
| 98 | Pelvic girdle muscle weakness (HP:0003749) | 1.89077193 |
| 99 | Calcaneovalgus deformity (HP:0001848) | 1.89026493 |
| 100 | Aneurysm (HP:0002617) | 1.88963278 |
| 101 | Dicarboxylic aciduria (HP:0003215) | 1.88260369 |
| 102 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.88260369 |
| 103 | Abnormality of nail color (HP:0100643) | 1.88159285 |
| 104 | Shallow orbits (HP:0000586) | 1.87421548 |
| 105 | Hypoalphalipoproteinemia (HP:0003233) | 1.87327155 |
| 106 | EMG: neuropathic changes (HP:0003445) | 1.86360217 |
| 107 | Back pain (HP:0003418) | 1.85938454 |
| 108 | Malignant hyperthermia (HP:0002047) | 1.85161334 |
| 109 | Generalized muscle weakness (HP:0003324) | 1.84908815 |
| 110 | Gowers sign (HP:0003391) | 1.84109487 |
| 111 | Abnormality of the hip-girdle musculature (HP:0001445) | 1.83240796 |
| 112 | Abnormality of the musculature of the pelvis (HP:0001469) | 1.83240796 |
| 113 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.83046787 |
| 114 | Sudden cardiac death (HP:0001645) | 1.82992627 |
| 115 | Popliteal pterygium (HP:0009756) | 1.82778171 |
| 116 | Abnormality of the umbilical cord (HP:0010881) | 1.81773633 |
| 117 | Hip contracture (HP:0003273) | 1.79922290 |
| 118 | Abnormality of the neuromuscular junction (HP:0003398) | 1.77450962 |
| 119 | Fatigable weakness (HP:0003473) | 1.77450962 |
| 120 | Cervical subluxation (HP:0003308) | 1.76807088 |
| 121 | Atrophic scars (HP:0001075) | 1.75289485 |
| 122 | Ketosis (HP:0001946) | 1.74656330 |
| 123 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.74291456 |
| 124 | Hepatic necrosis (HP:0002605) | 1.73272302 |
| 125 | Pulmonary artery stenosis (HP:0004415) | 1.73049912 |
| 126 | Lower limb amyotrophy (HP:0007210) | 1.72613308 |
| 127 | * Muscular dystrophy (HP:0003560) | 1.71985130 |
| 128 | Left ventricular hypertrophy (HP:0001712) | 1.71810705 |
| 129 | Nausea (HP:0002018) | 1.71315013 |
| 130 | Trismus (HP:0000211) | 1.70529333 |
| 131 | Progressive muscle weakness (HP:0003323) | 1.69768560 |
| 132 | Ulnar bowing (HP:0003031) | 1.68810838 |
| 133 | Skin nodule (HP:0200036) | 1.68801301 |
| 134 | Aortic dissection (HP:0002647) | 1.66048782 |
| 135 | Vertebral compression fractures (HP:0002953) | 1.65793497 |
| 136 | Wrist flexion contracture (HP:0001239) | 1.65258192 |
| 137 | Lymphangioma (HP:0100764) | 1.64312447 |
| 138 | Hyperglycemia (HP:0003074) | 1.64043306 |
| 139 | * Congestive heart failure (HP:0001635) | 1.63506678 |
| 140 | Conjunctival hamartoma (HP:0100780) | 1.62992863 |
| 141 | Mesangial abnormality (HP:0001966) | 1.61464611 |
| 142 | Limb-girdle muscle weakness (HP:0003325) | 1.59946720 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TTN | 5.32383302 |
| 2 | TRIB3 | 3.39777999 |
| 3 | LMTK2 | 2.89066410 |
| 4 | TSSK6 | 2.85966708 |
| 5 | OBSCN | 2.73660875 |
| 6 | MYLK | 2.70956606 |
| 7 | PHKG2 | 2.66572592 |
| 8 | PHKG1 | 2.66572592 |
| 9 | ERN1 | 2.45433426 |
| 10 | DMPK | 2.42337606 |
| 11 | PKN2 | 2.30774117 |
| 12 | MAPKAPK5 | 2.29364862 |
| 13 | PDK4 | 2.28604805 |
| 14 | PDK3 | 2.28604805 |
| 15 | IRAK3 | 2.22271034 |
| 16 | BCKDK | 2.18907136 |
| 17 | ARAF | 2.05592026 |
| 18 | PDK2 | 2.05095600 |
| 19 | TESK1 | 1.99412187 |
| 20 | TIE1 | 1.94512504 |
| 21 | PNCK | 1.88729581 |
| 22 | LATS2 | 1.78940554 |
| 23 | MAP3K3 | 1.75273764 |
| 24 | MUSK | 1.74731224 |
| 25 | PIK3CA | 1.70129494 |
| 26 | EPHB1 | 1.67751473 |
| 27 | RIPK1 | 1.59181296 |
| 28 | MAP3K9 | 1.47871283 |
| 29 | EPHA3 | 1.47452649 |
| 30 | MAPK15 | 1.47336133 |
| 31 | MAPKAPK3 | 1.45005359 |
| 32 | PINK1 | 1.42712640 |
| 33 | PDGFRA | 1.42606752 |
| 34 | TGFBR2 | 1.42024170 |
| 35 | WEE1 | 1.38553544 |
| 36 | STK38L | 1.38367067 |
| 37 | ICK | 1.34089641 |
| 38 | LATS1 | 1.33044053 |
| 39 | SIK1 | 1.32145975 |
| 40 | MAP2K3 | 1.27982481 |
| 41 | STK24 | 1.27192391 |
| 42 | EPHB2 | 1.24718139 |
| 43 | FGFR4 | 1.23105694 |
| 44 | NEK1 | 1.19842559 |
| 45 | FER | 1.19205905 |
| 46 | TRPM7 | 1.18783389 |
| 47 | DDR2 | 1.17199463 |
| 48 | PRKD1 | 1.16506357 |
| 49 | PAK3 | 1.12885042 |
| 50 | PIM2 | 1.10658932 |
| 51 | KDR | 1.03984011 |
| 52 | SMG1 | 1.03609516 |
| 53 | TAOK2 | 1.02195732 |
| 54 | NEK9 | 1.01042862 |
| 55 | MAP3K13 | 0.98749776 |
| 56 | ERBB4 | 0.98665362 |
| 57 | GRK7 | 0.96658476 |
| 58 | MAP3K12 | 0.96029135 |
| 59 | ILK | 0.95899027 |
| 60 | RPS6KB2 | 0.94887247 |
| 61 | ROCK1 | 0.90787488 |
| 62 | MAP3K11 | 0.88871594 |
| 63 | KSR2 | 0.88669710 |
| 64 | PIK3CG | 0.87400451 |
| 65 | EPHA2 | 0.87296253 |
| 66 | PTK6 | 0.84124854 |
| 67 | NME2 | 0.84121015 |
| 68 | CAMK2G | 0.82863291 |
| 69 | EEF2K | 0.82301570 |
| 70 | MAP3K5 | 0.80743492 |
| 71 | CAMK2D | 0.80650055 |
| 72 | MAPK12 | 0.79129140 |
| 73 | BMX | 0.75359757 |
| 74 | NTRK1 | 0.74148112 |
| 75 | PRPF4B | 0.74056841 |
| 76 | TBK1 | 0.73381057 |
| 77 | BRAF | 0.71385571 |
| 78 | CDC42BPA | 0.69059333 |
| 79 | PTK2 | 0.68351550 |
| 80 | ZAK | 0.65341965 |
| 81 | MAP3K7 | 0.64335956 |
| 82 | FLT3 | 0.64246419 |
| 83 | MAP2K1 | 0.63521843 |
| 84 | PRKAA2 | 0.63493841 |
| 85 | PRKG2 | 0.63000885 |
| 86 | WNK4 | 0.61236632 |
| 87 | PTK2B | 0.61122578 |
| 88 | SCYL2 | 0.59672954 |
| 89 | LRRK2 | 0.58538221 |
| 90 | PRKD3 | 0.58511527 |
| 91 | DAPK3 | 0.58162025 |
| 92 | TAOK1 | 0.58071631 |
| 93 | MAP2K2 | 0.57601484 |
| 94 | RPS6KA6 | 0.56402174 |
| 95 | RPS6KL1 | 0.55794716 |
| 96 | RPS6KC1 | 0.55794716 |
| 97 | PRKAA1 | 0.55110699 |
| 98 | SIK3 | 0.55081674 |
| 99 | RPS6KA2 | 0.54236553 |
| 100 | * MTOR | 0.53922205 |
| 101 | MET | 0.51525013 |
| 102 | PAK2 | 0.51200288 |
| 103 | WNK1 | 0.50108265 |
| 104 | MST1R | 0.49139232 |
| 105 | JAK1 | 0.49005248 |
| 106 | CDK12 | 0.48156313 |
| 107 | RAF1 | 0.45317455 |
| 108 | PBK | 0.45017011 |
| 109 | MAP3K1 | 0.44327079 |
| 110 | PRKD2 | 0.44036690 |
| 111 | MAPKAPK2 | 0.43998071 |
| 112 | STK4 | 0.43963444 |
| 113 | INSRR | 0.42050271 |
| 114 | ROCK2 | 0.41716277 |
| 115 | STK3 | 0.41700997 |
| 116 | PAK4 | 0.40434305 |
| 117 | MOS | 0.40402688 |
| 118 | ABL2 | 0.40152365 |
| 119 | CAMK2B | 0.39617510 |
| 120 | TGFBR1 | 0.38117338 |
| 121 | PDPK1 | 0.38089107 |
| 122 | LIMK1 | 0.38001454 |
| 123 | GSK3A | 0.37786417 |
| 124 | AKT3 | 0.37429644 |
| 125 | CAMK4 | 0.37194746 |
| 126 | EIF2AK3 | 0.37078131 |
| 127 | KSR1 | 0.36139432 |
| 128 | RPS6KA4 | 0.36104088 |
| 129 | TYK2 | 0.35692065 |
| 130 | PRKCE | 0.34872068 |
| 131 | PRKCI | 0.34771207 |
| 132 | MAP3K2 | 0.34285318 |
| 133 | PAK1 | 0.34006280 |
| 134 | FGFR3 | 0.33568490 |
| 135 | NLK | 0.32425181 |
| 136 | MAP3K8 | 0.32369043 |
| 137 | AKT2 | 0.31852454 |
| 138 | PDGFRB | 0.31721812 |
| 139 | STK38 | 0.31344578 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 4.33129207 |
| 2 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.49346575 |
| 3 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 3.23541315 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.10916947 |
| 5 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 3.10685767 |
| 6 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.82595719 |
| 7 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 2.74112039 |
| 8 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.66986233 |
| 9 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 2.32676545 |
| 10 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.28452770 |
| 11 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.17145601 |
| 12 | Carbon metabolism_Homo sapiens_hsa01200 | 2.04087786 |
| 13 | Parkinsons disease_Homo sapiens_hsa05012 | 1.73317378 |
| 14 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.72758328 |
| 15 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.71490040 |
| 16 | Viral myocarditis_Homo sapiens_hsa05416 | 1.70185583 |
| 17 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.68443734 |
| 18 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.66561028 |
| 19 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.63467636 |
| 20 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.62725650 |
| 21 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.61645001 |
| 22 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.59475177 |
| 23 | Circadian rhythm_Homo sapiens_hsa04710 | 1.57113838 |
| 24 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.47690286 |
| 25 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.40648193 |
| 26 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.38849977 |
| 27 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.37651528 |
| 28 | Focal adhesion_Homo sapiens_hsa04510 | 1.37300613 |
| 29 | Insulin resistance_Homo sapiens_hsa04931 | 1.25096908 |
| 30 | Alzheimers disease_Homo sapiens_hsa05010 | 1.22440222 |
| 31 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.21927915 |
| 32 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.19698037 |
| 33 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.16733003 |
| 34 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.15268393 |
| 35 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.11737765 |
| 36 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.10650686 |
| 37 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.08006040 |
| 38 | Thyroid cancer_Homo sapiens_hsa05216 | 1.03987107 |
| 39 | Adherens junction_Homo sapiens_hsa04520 | 1.02977419 |
| 40 | Hippo signaling pathway_Homo sapiens_hsa04390 | 1.02701261 |
| 41 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.01954172 |
| 42 | Amoebiasis_Homo sapiens_hsa05146 | 1.00923762 |
| 43 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.99807901 |
| 44 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.97348788 |
| 45 | Galactose metabolism_Homo sapiens_hsa00052 | 0.95927996 |
| 46 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.95732306 |
| 47 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.94997425 |
| 48 | Huntingtons disease_Homo sapiens_hsa05016 | 0.93368873 |
| 49 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.92016628 |
| 50 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.87627101 |
| 51 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.85761922 |
| 52 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.83559752 |
| 53 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.82732606 |
| 54 | Endocytosis_Homo sapiens_hsa04144 | 0.82268196 |
| 55 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.81613986 |
| 56 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.80898739 |
| 57 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.80588011 |
| 58 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.80145080 |
| 59 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.79748339 |
| 60 | Melanogenesis_Homo sapiens_hsa04916 | 0.79421460 |
| 61 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.79094354 |
| 62 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.77506051 |
| 63 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.77466963 |
| 64 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.77072269 |
| 65 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.77065082 |
| 66 | Other glycan degradation_Homo sapiens_hsa00511 | 0.75881681 |
| 67 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.75133629 |
| 68 | Endometrial cancer_Homo sapiens_hsa05213 | 0.74697558 |
| 69 | Peroxisome_Homo sapiens_hsa04146 | 0.73023190 |
| 70 | Lysine degradation_Homo sapiens_hsa00310 | 0.72656257 |
| 71 | Malaria_Homo sapiens_hsa05144 | 0.70391138 |
| 72 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.70297444 |
| 73 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.69901740 |
| 74 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.69105685 |
| 75 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.67305143 |
| 76 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.66393940 |
| 77 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.66025643 |
| 78 | Tight junction_Homo sapiens_hsa04530 | 0.66021442 |
| 79 | Glioma_Homo sapiens_hsa05214 | 0.65681205 |
| 80 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.65119277 |
| 81 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.64493887 |
| 82 | Prostate cancer_Homo sapiens_hsa05215 | 0.64083336 |
| 83 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.63814809 |
| 84 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.61889569 |
| 85 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.60859688 |
| 86 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.60608142 |
| 87 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.59690886 |
| 88 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.59449659 |
| 89 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.59148666 |
| 90 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.59049430 |
| 91 | Axon guidance_Homo sapiens_hsa04360 | 0.58203396 |
| 92 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.57469670 |
| 93 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.56835663 |
| 94 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.56198402 |
| 95 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.55840808 |
| 96 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.53492948 |
| 97 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.53376010 |
| 98 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.53216699 |
| 99 | Bile secretion_Homo sapiens_hsa04976 | 0.52582628 |
| 100 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.51852797 |
| 101 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.51003637 |
| 102 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.49083885 |
| 103 | Bladder cancer_Homo sapiens_hsa05219 | 0.49030388 |
| 104 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.48860070 |
| 105 | Pathways in cancer_Homo sapiens_hsa05200 | 0.47550368 |
| 106 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.46408761 |
| 107 | Legionellosis_Homo sapiens_hsa05134 | 0.46264061 |
| 108 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.45705822 |
| 109 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.44944542 |
| 110 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.44358016 |
| 111 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.44180116 |
| 112 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.44156873 |
| 113 | Melanoma_Homo sapiens_hsa05218 | 0.44023915 |
| 114 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.43767277 |
| 115 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.43622757 |
| 116 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.43511073 |
| 117 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.43346489 |
| 118 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.43021894 |
| 119 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.42952721 |
| 120 | Prion diseases_Homo sapiens_hsa05020 | 0.42470795 |
| 121 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.42211888 |
| 122 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.41617543 |
| 123 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.39615018 |
| 124 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.38898140 |
| 125 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.38759330 |
| 126 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.37309609 |
| 127 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.37303926 |
| 128 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.32974227 |
| 129 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.32713099 |
| 130 | Salmonella infection_Homo sapiens_hsa05132 | 0.32605678 |
| 131 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.32523114 |
| 132 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.31412807 |
| 133 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.31128312 |
| 134 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.30406896 |
| 135 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.30222387 |
| 136 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.29354238 |
| 137 | Lysosome_Homo sapiens_hsa04142 | 0.26019998 |
| 138 | Sulfur relay system_Homo sapiens_hsa04122 | 0.25075543 |
| 139 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.24708315 |
| 140 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.23896027 |
| 141 | Leishmaniasis_Homo sapiens_hsa05140 | 0.23768317 |

